Radiotherapy and image-guidance solutions company Resonant Medical has signed a purchase agreement with U.S. group purchasing organization Amerinet for the delivery of the company’s Image-Guided Radiation Therapy (IGRT) solution.  Via the terms of the three-year contract, Resonant Medical will provide hospitals and cancer clinics with its FDA-cleared Clarity System for the treatment of soft tissue cancers through Amerinet, said the organization.

The solution is compatible with any make, model or year of linear accelerator and CT scanner, and all Amerinet members will be able to purchase the system under the cost effective product configuration solutions of the contract, Amerinet said.